Dr. Deming is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-265-1700Fax+1 608-890-7127
Education & Training
- University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2010 - 2012
- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2007 - 2010
- University of Wisconsin School of Medicine & Public HealthClass of 2007
Certifications & Licensure
- WI State Medical License 2009 - 2025
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver Start of enrollment: 2020 Mar 16
- Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04) Start of enrollment: 2020 Jun 23
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 821 citationsColon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Mustafa A. Arain, Yi Jen Chen
Journal of the National Comprehensive Cancer Network. 2021-03-02 - 627 citationsNCCN Guidelines® Insights Colon Cancer, Version 2.2018 Featured Updates to the NCCN GuidelinesAl B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Lynette Cederquist, Yi Jen Chen
Journal of the National Comprehensive Cancer Network. 2018-04-01 - 1 citationsMulti-ancestral origin of intestinal tumors: Impact on growth, progression, and drug efficacy.Alyssa A. Leystra, Brock J Gilsdorf, Amanda M. Wisinger, Elise R Warda, Shanna Wiegand
Cancer Reports. 2021-07-10
Press Mentions
- Monitoring ctDNA After Colorectal Cancer SurgeryFebruary 2nd, 2023
- Cell-Free, Worry-Free: $10,000 Grant Expands Free Access to Personalized Cancer TestFebruary 28th, 2020
- UW Carbone Experts Lead Sessions at World's Largest Cancer MeetingMay 31st, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: